Losartan Shows Promise in Activating Brown Fat to Boost Metabolism

How Losartan Influences Fat Tissue Function

Researchers from Weill Cornell Medicine, Rockefeller University, and Memorial Sloan Kettering Cancer Center have found that losartan, a widely used medication for treating high blood pressure, can stimulate brown adipose tissue—commonly known as brown fat—and enhance its metabolic activity. In preclinical models, the drug increased the body’s ability to burn calories by activating this specialized fat tissue, which generates heat to maintain body temperature. The discovery opens new possibilities for repurposing an existing drug to address metabolic disorders such as obesity and type 2 diabetes, leveraging its known safety profile in patients.

Wellness Alert

New Depression Subtype Linked to Body Clock IdentifiedAI Facial Analysis Predicts Cancer Survival RatesOptimizing Daily Habits for Improved Digestive FunctionRapport Therapeutics Reports Positive Phase 2 Results for RAP-219 in Bipolar Mania

The study revealed that losartan works by blocking angiotensin II receptors, which not only helps lower blood pressure but also reduces inhibition on brown fat activity. When these receptors are blocked, brown fat cells become more active, increasing their uptake of glucose and fatty acids to produce heat. Researchers observed heightened mitochondrial activity in brown fat tissue, indicating a direct boost in energy expenditure. This mechanism suggests that losartan may shift the body’s energy balance toward burning stored fat rather than storing it, offering a dual benefit for patients with hypertension and metabolic concerns.

Could This Lead to New Weight Management Strategies?

While the findings are promising, the research remains in early stages, conducted primarily in animal models. Scientists caution that human responses may vary, and clinical trials are needed to determine whether losartan produces similar metabolic effects in people. Nonetheless, because losartan is already approved and widely used, repurposing it for metabolic health could accelerate development timelines. Researchers are now exploring optimal dosing and long-term impacts to assess viability for broader therapeutic use beyond blood pressure control.

What is brown fat and why is it important? Brown fat is a type of fat tissue that burns calories to generate heat, helping regulate body temperature and metabolism. Unlike white fat, which stores energy, brown fat actively consumes energy, making it a target for treating obesity and metabolic diseases.

Frequently Asked Questions

Is losartan currently prescribed for weight loss or metabolic issues? No, losartan is approved only for treating high blood pressure and certain heart conditions. Its effects on brown fat and metabolism are still under investigation and not yet recognized as an approved use for weight management.

Are there risks in using losartan for metabolic benefits? As with any medication, losartan carries potential side effects such as dizziness, elevated potassium levels, or kidney function changes. Using it for off-label purposes should only occur under medical supervision and after further clinical validation.